| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 272 |
| 1 | ACETAMINOPHEN | 193 |
| 2 | TOFACITINIB | 189 |
| 3 | PREDNISONE | 181 |
| 4 | SECUKINUMAB | 168 |
| 5 | POLYETHYLENE GLYCOL 3350 | 167 |
| 6 | IBUPROFEN | 137 |
| 7 | RIMEGEPANT SULFATE | 133 |
| 8 | METHOTREXATE SODIUM | 131 |
| 9 | METHOTREXATE | 115 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 12 | 0.0165 |
| 1 | TASIMELTEON | 95 | 0.0161 |
| 2 | INFLIXIMAB-DYYB | 49 | 0.0142 |
| 3 | RIMEGEPANT SULFATE | 133 | 0.0102 |
| 4 | MEPIVACAINE HYDROCHLORIDE | 11 | 0.0095 |
| 5 | DARIDOREXANT | 26 | 0.0094 |
| 6 | AMIFAMPRIDINE PHOSPHATE | 23 | 0.0078 |
| 7 | IBUPROFEN, ACETAMINOPHEN | 20 | 0.0072 |
| 8 | DOXYLAMINE SUCCINATE | 42 | 0.0069 |
| 9 | PITOLISANT HYDROCHLORIDE | 14 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 412 |
| 1 | Corticosteroid [EPC] | 266 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 220 |
| 3 | Osmotic Laxative [EPC] | 204 |
| 4 | Benzodiazepine [EPC] | 196 |
| 5 | Interleukin-17A Antagonist [EPC] | 176 |
| 6 | Aromatic Amino Acid [EPC] | 155 |
| 7 | Insulin Analog [EPC] | 122 |
| 8 | Expectorant [EPC] | 118 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 114 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 32 | 0.0154 |
| 1 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 2 | Melatonin Receptor Agonist [EPC] | 97 | 0.0073 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 16 | 0.0067 |
| 4 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 25 | 0.0050 |
| 6 | Interleukin-17A Antagonist [EPC] | 176 | 0.0047 |
| 7 | Nitrogen Binding Agent [EPC] | 11 | 0.0046 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 30 | 0.0043 |
| 9 | Non-Standardized House Dust Allergenic Extract [EPC] | 3 | 0.0040 |